farnesol has been researched along with 2019 Novel Coronavirus Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Banin, E; Catelani, T; Fiandra, L; Ivanova, A; Ivanova, K; Jacobi, G; Mantecca, P; Natan, M; Tzanov, T | 1 |
1 other study(ies) available for farnesol and 2019 Novel Coronavirus Disease
Article | Year |
---|---|
Antibacterial, Antibiofilm, and Antiviral Farnesol-Containing Nanoparticles Prevent
Topics: Anti-Bacterial Agents; Antiviral Agents; Biofilms; COVID-19; Drug Resistance, Multiple; Farnesol; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Nanoparticles; SARS-CoV-2; Staphylococcal Infections; Staphylococcus aureus | 2022 |